已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

医学 中期分析 达比加群 内科学 肺栓塞 临床试验 低分子肝素 人口 深静脉 华法林 肝素 拜瑞妥 血栓形成 外科 心房颤动 环境卫生
作者
Frederikus A. Klok,Gerrit Toenges,Anna C. Mavromanoli,Stefano Barco,Walter Ageno,Hélène Bouvaist,Marianne Brodmann,Claudio Cuccia,Françis Couturaud,Claudia Dellas,Konstantinos Dimopoulos,Daniel Duerschmied,Klaus Empen,Pompilio Faggiano,Émile Ferrari,Nazzareno Galiè,Marcello Galvani,Alexandre Ghuysen,George Giannakoulas,Menno V. Huisman,David Jiménez,Matija Kozak,Iréne Lang,Mareike Lankeit,Nicolas Méneveau,Thomas Münzel,Massimiliano Palazzini,Antoniu Octavian Petriş,Giancarlo Piovaccari,Aldo Salvi,Sebastian Schellong,Kai‐Helge Schmidt,Franck Verschuren,Irene Schmidtmann,Guy Meyer,Stavros Konstantinides,Jaime Antonio,Abelaira Freire,Walter Ageno,İbrahim Akın,Toni Anušić,Laurent Bertoletti,Dorothea Becker,Laurent Bertoletti,Giuseppe Bettoni,Harald Binder,Marianne Brodmann,Hélène Bouvaist,Joachim H. Ficker,Claudio Cuccia,Françis Couturaud,Claudia Dellas,Giuseppe Sangiorgi,Konstantinos Dimopoulos,Daniel Duerschmied,Klaus Empen,Iolanda Enea,Pompilio Faggiano,Émile Ferrari,Joachim H. Ficker,Nazzareno Galiè,Marcello Galvani,Sabine Genth‐Zotz,George Giannakoulas,Philippe Girard,Stanislav Gorbulev,Alexandre Ghuysen,Matthias Held,Lukas Hobohm,Nazzareno Galiè,David Jiménez,Frederikus A. Klok,Stavros Konstantinides,Matija Kozak,Kai Kronfeld,Iréne Lang,Mareike Lankeit,Walter Lehmacher,Concepcion Patricia Lopez Miguel,Nadine Martin,Anna C. Mavromanoli,Nicolas Méneveau,Guy Meyer,Thomas Münzel,Massimiliano Palazzini,Roman Parežnik,Antoniu Octavian Petriş,Giancarlo Piovaccari,Kurt Quitzau,Irinel Raluca Parepa,Purificación Ramírez Martín,Marc Righini,Aldo Salvi,Sebastian Schellong,Kai‐Helge Schmidt,Irene Schmidtmann,Gerrit Toenges,Silviu Bogdan Todea,Adam Torbicki,Luca Valerio,Thomas Vanassche,Franck Verschuren,L Vida-Simiti,Anamaria Wolf-Pütz
出处
期刊:The Lancet Haematology [Elsevier BV]
卷期号:8 (9): e627-e636 被引量:12
标识
DOI:10.1016/s2352-3026(21)00203-9
摘要

Background Current guidelines recommend a risk-adjusted treatment strategy for the management of acute pulmonary embolism. This is a particular patient category for whom optimal treatment (anticoagulant treatment, reperfusion strategies, and duration of hospitalisation) is currently unknown. We investigated whether treatment of acute intermediate-risk pulmonary embolism with parenteral anticoagulation for a short period of 72 h, followed by a switch to a direct oral anticoagulant (dabigatran), is effective and safe. Methods We did a multinational, multicentre, single-arm, phase 4 trial at 42 hospitals in Austria, Belgium, France, Germany, Italy, Netherlands, Romania, Slovenia, and Spain. Adult patients (aged ≥18 years) with symptomatic intermediate-risk pulmonary embolism, with or without deep-vein thrombosis, were enrolled. Patients received parenteral low-molecular-weight or unfractionated heparin for 72 h after diagnosis of pulmonary embolism before switching to oral dabigatran 150 mg twice per day following a standard clinical assessment. The primary outcome was recurrent symptomatic venous thromboembolism or pulmonary embolism-related death within 6 months. The primary and safety outcomes were assessed in the intention-to-treat population. The study was terminated early, as advised by the data safety and monitoring board, following sample size adaptation after the predefined interim analysis on Dec 18, 2018. This trial is registered with the EU Clinical Trials Register (EudraCT 2015-001830-12) and ClinicalTrials.gov (NCT02596555). Findings Between Jan 1, 2016, and July 31, 2019, 1418 patients with pulmonary embolism were screened, of whom 402 were enrolled and were included in the intention-to-treat analysis (median age was 69·5 years [IQR 60·0–78·0); 192 [48%] were women and 210 [52%] were men). Median follow-up was 217 days (IQR 210–224) and 370 (92%) patients adhered to the protocol. The primary outcome occurred in seven (2% [upper bound of right-sided 95% CI 3]; p<0·0001 for rejecting the null hypothesis) patients, with all events occurring in those with intermediate-high-risk pulmonary embolism (seven [3%; upper bound of right-sided 95% CI 5] of 283). At 6 months, 11 (3% [95% CI 1–5]) of 402 patients had at least one major bleeding event and 16 (4% [2–6]) had at least one clinically relevant non-major bleeding event; the only fatal haemorrhage occurred in one (<1%) patient before the switch to dabigatran. Interpretation A strategy of early switch from heparin to dabigatran following standard clinical assessment was effective and safe in patients with intermediate-risk pulmonary embolism. Our results can help to refine guideline recommendations for the initial treatment of acute intermediate-risk pulmonary embolism, optimising the use of resources and avoiding extended hospitalisation. Funding German Federal Ministry of Education and Research, University Medical Center Mainz, and Boehringer Ingelheim.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
柠檬水发布了新的文献求助10
1秒前
量子星尘发布了新的文献求助30
2秒前
云栖完成签到,获得积分10
3秒前
4秒前
8秒前
hamalaoda完成签到,获得积分10
12秒前
1073980795发布了新的文献求助10
14秒前
15秒前
15秒前
Hshi完成签到 ,获得积分10
16秒前
Akim应助ZTX采纳,获得30
19秒前
19秒前
tingting发布了新的文献求助10
20秒前
23秒前
叶子兮完成签到,获得积分10
24秒前
英俊的铭应助沸腾鱼健康采纳,获得10
25秒前
U9A驳回了554802336应助
25秒前
XLC发布了新的文献求助30
26秒前
xx发布了新的文献求助30
27秒前
29秒前
思源应助大笑的觅珍采纳,获得10
30秒前
30秒前
33秒前
Gaara0504发布了新的文献求助10
33秒前
MissZhang发布了新的文献求助10
33秒前
酷波er应助SSS水鱼采纳,获得10
33秒前
爱包的馒完成签到,获得积分10
34秒前
柠檬水发布了新的文献求助10
34秒前
FashionBoy应助焦立超采纳,获得10
35秒前
ZTX完成签到,获得积分10
36秒前
腼腆的康完成签到 ,获得积分10
38秒前
38秒前
研友_VZG7GZ应助MissZhang采纳,获得10
41秒前
长江完成签到 ,获得积分10
43秒前
43秒前
王珺发布了新的文献求助10
43秒前
芯之痕应助文件撤销了驳回
44秒前
Jay发布了新的文献求助10
47秒前
47秒前
少川完成签到 ,获得积分10
48秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976531
求助须知:如何正确求助?哪些是违规求助? 3520603
关于积分的说明 11204100
捐赠科研通 3257210
什么是DOI,文献DOI怎么找? 1798648
邀请新用户注册赠送积分活动 877835
科研通“疑难数据库(出版商)”最低求助积分说明 806570